In these experiments, we proved that the neuroprotective effect of EA is related to the JNK signaling pathway that mediates neuronal apoptosis. EA could prevent cognitive dysfunction mediated by cerebral ischemia-reperfusion injury by regulating both JNK transcription-dependent pathway and JNK transcription-independent route. EA inhibited the expression of JNK-3, AP-1, and P53 to regulate the neuronal apoptosis program mediated by JNK transcription-dependent pathway. In addition, EA decreased the expression of Bax and increased the expression of Bcl-2 to regulate the neuronal apoptosis program mediated by JNK transcription-independent route.
VaD refers to severe cognitive dysfunction syndrome caused by ischemic stroke, hemorrhagic stroke, and cerebrovascular disease that causes hypoperfusion of brain areas such as memory, cognition, and behavior. Many studies have proved that the death of nerve cells caused by whole brain or local cerebral ischemia is mainly apoptosis (Endo H et al. 2006; Wang HQ et al. 2007). Ischemia–reperfusion induced cerebral injury is one of more commonly employed models to induce vascular dementia in animals (Wu L et al. 2015; Wan L et al. 2015). In the present study, a state of cerebral ischemia reperfusion was induced by occlusion of both carotid arteries.
The BCCAo model has been developed and been widely used in global ischemia studies in mice (Spray S et al. 2016; Soares LM et al. 2013; Wahul AB et al. 2018). C57BL/6 mice have been widely used in the production of global cerebral ischemia models. They are easily affected by neurological deficits and brain damage, and the carotid artery of the carotid artery is simply and briefly occluded (Berry K et al. 1975), even as short as 5 minutes. Compared with other strains of mice, C57BL/6 mice undergoing BCCAo surgery showed reliable ischemic neurological symptoms, and had highly reproducible histological damage in the hippocampus and papillae (Yang G et al. 1997).
The JNK signaling pathway is one of the key pathways that mediate cell apoptosis, which plays a role in the cell apoptosis of various organs. In recent years, studies have found that the activation of the JNK signaling pathway can mediate ovarian granulosa cell apoptosis, and the mitochondrial apoptosis of pancreatic cancer is also closely related to the activation of JNK (Yang H et al. 2017; Zhang X et al. 2019). What’s more, the vascular dementia models typically exhibit downregulated anti-apoptotic Bcl-2 and upregulated pro-apoptotic Bax, cleaved caspase-3, and cleaved-PARP levels in the brain, for which modulated p38 MAPK and JNK phosphorylation pathways play a vital role (Wang XX et al. 2020). Our previous studies have found that EA treatment can enhance the expression of endogenous BDNF, thereby improving the living environment of neurons in the brain and inhibiting hippocampal cell apoptosis (Zhao J et al. 2013). The present study showed EA could alleviate cognitive dysfunction, which may be achieved by regulating the JNK signaling pathway and inhibiting hippocampal nerve cell apoptosis.
The JNK of resting cells is mainly located in the cytoplasm. When activated by stimulators, the partially activated JNK is translocated to the nucleus and activated by phosphorylation to activate a variety of nuclear transcription factors, such as activated protein-1 (AP-1), P53 and so on (Davis RJ 2000; Pei H et al. 2016). After AP-1 activity is enhanced, it promotes P53 protein expression (Shaulian E et al. 2001). In recent years, studies have found that inhibiting the activity of JNK can reduce neuronal apoptosis in cerebral ischemic diseases (Wen XR et al. 2016). In present study, we found that BCCAo could increase the activity of JNK-3, AP-1 and P53. In addition, the results also showed that EA could inhibit the expression of JNK-3, AP-1 and P53. It is speculated that the therapeutic effect of EA may be through the regulation of JNK transcription-dependent pathway.
JNK signaling pathway can not only regulate the transcription of target genes in the nucleus, but also rapidly exert corresponding biological effects by directly regulating the structure and function of cytoplasmic substrates. A part of activated JNK stays in the cytoplasm and directly regulates the activity of Bcl-2 family members (Bim, Bax, Bcl-2, etc.) through phosphorylation, thereby mediating apoptosis in the mitochondrial pathway (Bogoyevitch MA et al. 2006; Carboni S et al. 2005; Tournier C et al. 2000; Perier C et al. 2007). This process does not rely on the expression of new genes. The Bcl-2 family is the main regulator of the JNK transcription-independent route. It is divided into three categories: pro-apoptotic proteins, such as Bak and Bax; anti-apoptotic proteins, such as Bcl-2 and Bcl-xL, and BH3- such as Bim and Bid. only protein. Among them, Bax is the main mediator of the mitochondrial pathway (Bogoyevitch MA et al. 2006; Perier C et al. 2007). Activated Bax translocates to the outer mitochondrial membrane to increase the permeability of the mitochondrial membrane and release pro-apoptotic mitochondrial proteins (Perier C et al. 2007). Mitochondrial proteins released into the cytoplasm initiates the caspase-dependent mitochondrial pathway of apoptosis by forming apoptotic bodies. Caspase-3 is a key factor in the process of cell apoptosis and is called the executor of cell apoptosis (Fan TJ et al. 2005). Our current study found that the expression of Bcl-2 decreased in the hippocampus of BCCAo model mice, while the expression of Bax and Caspase-3 increased. The research results also showed that EA could increase the expression of Bcl-2 and reduce the expression of Bax and Caspase-3. It is speculated that EA may play a neuroprotective effect by regulating the JNK mitochondrial pathway.
In summary, this study showed possible mechanisms by which EA at DU20, BL17 and BL23 promotes functional recovery in VaD mice. EA inhibited apoptosis of hippocampal neurons, improved cognitive impairment, and down-regulated the expression of JNK-3, AP-1, P53, Bax, Caspase-3 and up-regulated the expression of Bcl-2 in VaD mice. The mechanism of action of EA to treat VaD may be related to its regulation of JNK transcription-dependent pathway and JNK transcription-independent route. These investigations provided new insights into the mechanism of EA-induced anti-apoptotic effects in VaD.